Department of Ophthalmology V, Centre Hospitalier National d'Ophtalmologie des XV-XX, Institut de la Vision, UMR S968, INSERM, UPMC Univ Paris 06, Paris, France.
Cornea. 2013 Feb;32(2):130-6. doi: 10.1097/ICO.0b013e31826429bd.
The objective of this study was to assess the factors associated with anatomical and visual outcomes in patients presenting with Acanthamoeba keratitis (AK).
This is a retrospective noncomparative interventional case series study comprising 44 eyes from 42 patients presenting with AK, treated with topical hexamidine diisethionate and topical polyhexamethylene biguanide, monitored between 2004 and 2008. AK was confirmed by polymerase chain reaction or direct microscopic examination. Correlation between clinical presentation and prognosis was assessed. Anatomical outcome was assessed according to the percentage of eyes requiring at least 1 surgical procedure in addition to topical treatment. Visual outcome was assessed by the best-corrected visual acuity at the end of follow-up.
Polymerase chain reaction results were positive for Acanthamoeba in 40 of the 44 eyes (91%) and in 16 of the 44 eyes (36%) by direct microscopic examination. Confocal microscopy suggested the presence of Acanthamoeba in 12 of 19 eyes (63%). Amniotic membrane transplantation was performed in 8 eyes, penetrating keratoplasty in 4 eyes, and evisceration in 2 eyes. The average follow-up time was 10 months. Surgical treatment was significantly associated (P < 0.05) with time from symptom onset to diagnosis of >30 days, an initial visual acuity of ≤20/200, an infiltrate size of >3 mm, preperforating infiltrates, and corneal neovascularization. The average final visual acuity was 20/48 in eyes that did not require surgical treatment (n = 34) and 20/1702 in eyes that required at least 1 surgical procedure (n = 10; P < 0.0001).
Late diagnosis, low initial visual acuity, corneal neovascularization, large infiltrates, and preperforated infiltrates were associated with surgical treatment in patients presenting with AK. Surgical intervention was associated with worse visual outcome.
本研究旨在评估棘阿米巴角膜炎(AK)患者的解剖和视觉结局相关因素。
这是一项回顾性非对照干预性病例系列研究,纳入了 2004 年至 2008 年间就诊的 42 例 AK 患者的 44 只眼,这些患者接受了局部六亚甲基双胍二碘和局部聚六亚甲基双胍治疗。AK 通过聚合酶链反应或直接显微镜检查得到确认。评估了临床表现与预后的相关性。根据需要手术治疗的眼数(除了局部治疗)评估解剖学结局。根据最终随访时的最佳矫正视力评估视觉结局。
44 只眼中有 40 只(91%)和 16 只(36%)通过直接显微镜检查发现棘阿米巴阳性。19 只眼中的 12 只(63%)通过共焦显微镜提示存在棘阿米巴。8 只眼进行了羊膜移植,4 只眼进行了穿透性角膜移植,2 只眼进行了眼内容剜除。平均随访时间为 10 个月。手术治疗与症状发作至确诊时间>30 天(P<0.05)、初始视力≤20/200、浸润大小>3 毫米、前穿孔性浸润和角膜新生血管形成显著相关。未行手术治疗的 34 只眼(n=34)的平均最终视力为 20/48,而行至少 1 次手术治疗的 10 只眼(n=10)的平均最终视力为 20/1702(P<0.0001)。
在 AK 患者中,晚期诊断、初始视力低、角膜新生血管形成、大的浸润和前穿孔性浸润与手术治疗相关。手术干预与较差的视觉结局相关。